Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,689.90
-34.40 (-2.00%)
At close: May 29, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 323.29 billion as of June 1, 2026. Its market cap has increased by 64.50% in one year.
Market Cap
323.29B
Enterprise Value
337.29B
Revenue
92.04B
Ranking
n/a
PE Ratio
34.97
Stock Price
1,689.90
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 323.29B, an increase of 25.82%. That is a compound annual growth rate of 12.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 323.29B | 24.98% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 571.12B |
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |
| Rubicon Research | 165.67B |
| Jubilant Pharmova | 157.38B |
| Caplin Point Laboratories | 154.31B |